Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPERA: Oral JAK inhibitor Pharmacogenomics and Exposure-Response in Japanese Ulcerative Colitis Patients During COVID-19
jRCT1011210031Recruiting
- Sponsor
- Sapporo Medical University Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tofacitinib in autoimmune colitis, sponsored by Sapporo Medical University Hospital. Started Aug 2021; status: recruiting.
02
Drugs
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT1011210031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011210031.